Prader-Willi Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2128
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Prader-Willi Syndrome Market ?
Prader-Willi Syndrome Market is expected to grow at a CAGR of 4.5% during the forecast period 2024-2031.
Who are the key players in Prader-Willi Syndrome Market ?
Major players are Novartis, Soleno Therapeutics, Saniona, Pfizer, Millendo Therapeutics, Inc., Levo Therapeutics, Inc., Rhythm Pharmaceuticals, Essentialis, Inc., LG Corp and Novo Nordisk.
Related Reports
pharmaceuticalsFragile X Syndrome (Fxs) Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 27
Starting from
$4350
pharmaceuticalsHELLP Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
pharmaceuticalsAndersen-Tawil Syndrome Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 25
Starting from
$4350
pharmaceuticalsCarcinoid Syndrome Diarrhea Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
Starting from
$4350
pharmaceuticalsMorquio Syndrome Therapy Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 November 06
Starting from
$4350
pharmaceuticalsShort Bowel Syndrome Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 16
Starting from
$4350